Prenatal dexamethasone exposure-induced a gender-difference and sustainable multi-organ damage in offspring rats via serum metabolic profile analysis.


Journal

Toxicology letters
ISSN: 1879-3169
Titre abrégé: Toxicol Lett
Pays: Netherlands
ID NLM: 7709027

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 22 08 2018
revised: 01 08 2019
accepted: 08 09 2019
pubmed: 15 9 2019
medline: 23 10 2019
entrez: 15 9 2019
Statut: ppublish

Résumé

Prenatal dexamethasone exposure (PDE) induces developmental toxicities of multiple organs in offspring, but its serum metabolic profile changes before and after birth are unclear. Here, we employed a LC-MS-based metabolomic approach to detect serum metabolites of PDE offspring rats in utero and adulthood, and explore its change characteristics and toxicological significances. Meanwhile, the bodyweight, serum index related to hepatic and renal function were detected. As compared to healthy control rats, PDE reduced offspring birthweight but caused postnatal catch-up growth accompanied by adult liver and kidney function injury. In utero, the differential metabolites in response to PDE were mainly manifested as enhanced glycolysis, increased protein breakdown and disordered lipid metabolism, and multiple metabolic pathways were changed, which displayed gender differences. In adulthood, PDE offspring showed fewer and inconsistent types of differential metabolites compared to those in utero, which exhibited significant gender differences. The main differential metabolites induced by PDE included lactic acid, carnitine, cortexolone, bile acid, phosphatidylcholine, uric acid and platelet activating factor, which may participate in dexamethasone multi-organ toxicities and multi-disease susceptibility. In conclusion, PDE could induce a gender-difference and sustainable multi-organ damage in the offspring rats via serum metabolic profile analysis, which will enhance offspring susceptibility to multiple adult diseases.

Identifiants

pubmed: 31520701
pii: S0378-4274(18)31780-6
doi: 10.1016/j.toxlet.2019.09.007
pii:
doi:

Substances chimiques

Biomarkers 0
Glucocorticoids 0
Dexamethasone 7S5I7G3JQL

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

136-146

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Guanghui Chen (G)

Department of Pharmacology, School of Basic Medical Science of Wuhan University, Wuhan, 430071, China.

Hao Xiao (H)

Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.

Jinzhi Zhang (J)

Department of Pharmacology, School of Basic Medical Science of Wuhan University, Wuhan, 430071, China.

Huizhen Zhang (H)

School of Pharmaceutical Sciences, Sun Yat-sen University, 132# Waihuandong Road, Guangzhou University City, Guangzhou, 510006, China.

Bin Li (B)

Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.

Tao Jiang (T)

Department of Pharmacology, School of Basic Medical Science of Wuhan University, Wuhan, 430071, China.

Yajie Wen (Y)

School of Pharmaceutical Sciences, Sun Yat-sen University, 132# Waihuandong Road, Guangzhou University City, Guangzhou, 510006, China.

Yimin Jiang (Y)

School of Pharmaceutical Sciences, Sun Yat-sen University, 132# Waihuandong Road, Guangzhou University City, Guangzhou, 510006, China.

Kaili Fu (K)

School of Pharmaceutical Sciences, Sun Yat-sen University, 132# Waihuandong Road, Guangzhou University City, Guangzhou, 510006, China.

Dan Xu (D)

Department of Pharmacology, School of Basic Medical Science of Wuhan University, Wuhan, 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disorder, Wuhan, 430071, China.

Yu Guo (Y)

Department of Pharmacology, School of Basic Medical Science of Wuhan University, Wuhan, 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disorder, Wuhan, 430071, China.

Ying Ao (Y)

Department of Pharmacology, School of Basic Medical Science of Wuhan University, Wuhan, 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disorder, Wuhan, 430071, China.

Huichang Bi (H)

School of Pharmaceutical Sciences, Sun Yat-sen University, 132# Waihuandong Road, Guangzhou University City, Guangzhou, 510006, China. Electronic address: bihchang@mail.sysu.edu.cn.

Hui Wang (H)

Department of Pharmacology, School of Basic Medical Science of Wuhan University, Wuhan, 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disorder, Wuhan, 430071, China. Electronic address: wanghui19@whu.edu.cn.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH